1. Home
  2. CRVS vs CRTO Comparison

CRVS vs CRTO Comparison

Compare CRVS & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$10.60

Market Cap

843.7M

Sector

Health Care

ML Signal

N/A

Logo Criteo S.A.

CRTO

Criteo S.A.

N/A

Current Price

$15.41

Market Cap

751.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
CRVS
CRTO
Founded
2014
2005
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
843.7M
751.6M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
CRVS
CRTO
Price
$10.60
$15.41
Analyst Decision
Strong Buy
Buy
Analyst Count
7
11
Target Price
★ $31.50
$20.05
AVG Volume (30 Days)
★ 998.8K
309.3K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.04
38.95
EPS
N/A
★ 0.49
Revenue
N/A
★ $2,296,692,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.85
P/E Ratio
★ N/A
$31.92
Revenue Growth
N/A
★ 27.65
52 Week Low
$6.39
$13.95
52 Week High
$26.95
$25.29

Technical Indicators

Market Signals
Indicator
CRVS
CRTO
Relative Strength Index (RSI) 50.34 51.27
Support Level $9.21 $14.12
Resistance Level $10.81 $15.85
Average True Range (ATR) 0.64 0.62
MACD 0.12 0.16
Stochastic Oscillator 73.19 73.74

Price Performance

Historical Comparison
CRVS
CRTO

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

Share on Social Networks: